🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to compare the number of infusion reactions to treat...
Status
Completed
Location
St.Joseph Heritage Care
Start Date
2020-03-25
Trial ID
NCT04189588
Treatments Being Tested
Multiple Sclerosis (MS) is not only an 'inflammatory' demyelinating disease...
Status
Completed
Location
Dep. Neurology, Hospital of the University of Basel
Start Date
2012-09
Trial ID
NCT01765361
This study will evaluate the efficacy, safety and PK/PD of ocrelizumab at e...
Status
Terminated
Location
Chugoku region
Start Date
2008-10
Trial ID
NCT00779220
Treatments Being Tested
Multiple sclerosis is the most common inflammatory disease of the central n...
Status
Terminated
Location
Johns Hopkins University
Start Date
2021-10-01
Trial ID
NCT04767698
Treatments Being Tested
The MRI scan is one of the most important tools for diagnosing multiple scl...
Status
Completed
Location
Zuyderland MC
Start Date
2023-09-12
Trial ID
NCT05718947
Treatments Being Tested
This is a Phase IIIb, single-arm, multicenter, OLE study. Participants rece...
Status
Active Not Recruiting
Location
Barrow Neurological Institute
Start Date
2022-05-03
Trial ID
NCT05269004
Treatments Being Tested
The primary aim of this project is to determine whether there are differenc...
Status
Completed
Location
Brigham and Women's Hospital
Start Date
2021-11-18
Trial ID
NCT05131984
Treatments Being Tested
The main purpose of this study is to assess the bioequivalence of ocrelizum...
Status
Active Not Recruiting
Location
Profound Research, LLC
Start Date
2025-11-13
Trial ID
NCT07074886
Treatments Being Tested
The primary objective of this study is to assess the efficacy of Ocrelizuma...
Status
Completed
Location
RWJBarnabas Health
Start Date
2017-06-01
Trial ID
NCT03157830
A multicentre controlled phase II trial to compare the efficacy and safety ...
Status
Terminated
Location
Universitätsklinikum Hamburg-Eppendorf
Start Date
2021-08-27
Trial ID
NCT04971005
Treatments Being Tested